Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

OC 000459 in patients with eosinophilc oesophagitis

Trial Profile

OC 000459 in patients with eosinophilc oesophagitis

Status: Completed
Phase of Trial: Phase II

Latest Information Update: 21 Oct 2013

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Timapiprant (Primary)
  • Indications Eosinophilic oesophagitis
  • Focus Biomarker; Therapeutic Use
  • Most Recent Events

    • 16 Oct 2013 Results presented at the 21st United European Gastroenterology Week.
    • 26 May 2012 New trial record
    • 22 May 2012 Results presented at Digestive Disease Week 2012.
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top